NCT00066443 2026-03-27
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Completed
Clinical Trials
11 trialsNCT03568422 2026-03-27
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Active not recruiting
NCT04494958 2025-03-24
PALBOBIN
Fundacion Oncosur
Phase 1/2 Completed
NCT01138384 2023-08-04
Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Completed
NCT02236000 2023-01-26
A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer
NSABP Foundation Inc
Phase 1/2 Completed
NCT02129556 2019-02-15
PANACEA
ETOP IBCSG Partners Foundation
Phase 1/2 Completed
NCT00068263 2017-01-04
3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT00450892 2016-07-07
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1/2 Completed
NCT01495884 2015-10-26
The Myocet/Lapatinib Study. ICORG 10-03, V5
Cancer Trials Ireland
Phase 1/2 Terminated
NCT00002873 2013-07-19
Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT01089049 2012-03-26
Effect of a Natural Health Product on Urinary Estrogen Metabolites
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.
Phase 1/2 Completed